Lecture on K-Cell and Healthy Lifespan Extension
Discussion on Healthcare Collaboration Between Both Companies

Kwang-Yul Cha, Director of the Research Institute at Cha Hospital and Cha Bio Group, delivered a special lecture for employees of Hanwha General Insurance under the theme “K-Cell (Korean Induced Pluripotent Stem Cells), Longevity, and the Future of Korean Bio.”

They are posing for a commemorative photo after a special lecture by CHA Hospital, CHA Bio Group, and Hanwha General Insurance. CHA Hospital.

They are posing for a commemorative photo after a special lecture by CHA Hospital, CHA Bio Group, and Hanwha General Insurance. CHA Hospital.

View original image

Cha Hospital and Cha Bio Group announced on August 13 that Director Cha had given the lecture at the main conference hall of Hanwha General Insurance.


During the lecture, Director Cha highlighted the importance of prevention and healthy lifespan management, addressed how cell technology can be used to respond to low birth rates and population aging, introduced personalized stem cell and organ regeneration technologies based on K-Cell’s fundamental technology, and discussed global longevity and age-reversal technology trends. He also shared the research and business directions of Cha Hospital and Cha Bio Group centered on K-Cell.


Director Cha stated, “In order to develop high-quality cell therapies, it is necessary to undertake systematic research not only into cell function and safety, but also into genetic features related to healthy lifespan and diseases, such as FOXO3. By bringing together the research and business capabilities of the group, including CHA Biotech, we will further refine K-Cell technology for specific diseases and contribute to leading the global cell therapy market.”


After the lecture, major executives from both companies discussed cooperation strategies linking medical and biotechnology technologies with financial and insurance services for healthcare and wellness businesses. Both sides plan to expand their collaboration in health management services tailored to customers’ life cycles and in digital healthcare.



Chae-Beom Na, CEO of Hanwha General Insurance, commented, “I was able to broaden my understanding of ‘female longevity,’ where women live longer and healthier lives. It was a meaningful opportunity to consider the changes that advances in regenerative medicine and biotechnology will bring to insurance and healthcare services.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing